• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rallybio Corporation - Common Stock (NQ:RLYB)

    5.500 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 5.500
    Bid (Size) 5.080 (500)
    Ask (Size) 5.750 (300)
    Prev. Close 5.500
    Today's Range 5.500 - 5.500
    52wk Range 0.2201 - 5.625
    Shares Outstanding 37,747,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
    From Rallybio Corporation
    Via Business Wire
    News headline image
    Rallybio Announces Reverse Stock Split of Common Stock
    From Rallybio Corporation
    Via Business Wire

    Performance

    YTD
    +677.6%
    +677.6%
    1 Month
    +730.8%
    +730.8%
    3 Month
    +765.3%
    +765.3%
    6 Month
    +845.3%
    +845.3%
    1 Year
    +636.2%
    +636.2%

    More News

    Read More
    News headline image
    RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From Rallybio Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
    From Rallybio Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
    From Rallybio Corporation
    Via Business Wire
    News headline image
    Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    News headline image
    Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
    From Rallybio Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Top movers in Tuesday's session ↗
    Via Chartmill
    News headline image
    Most active stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Here's Why Shares in Recursion Pharmaceuticals Surged Today ↗
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Gapping stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Why Is Microcap Rallybio Stock Trading Higher On Tuesday? ↗
    Via Benzinga
    News headline image
    Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
    From Rallybio Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
    From Rallybio Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Rallybio Corporation - Common Stock publicly traded?
    Yes, Rallybio Corporation - Common Stock is publicly traded.
    What exchange does Rallybio Corporation - Common Stock trade on?
    Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Rallybio Corporation - Common Stock?
    The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
    What is the current price of Rallybio Corporation - Common Stock?
    The current price of Rallybio Corporation - Common Stock is 5.500
    When was Rallybio Corporation - Common Stock last traded?
    The last trade of Rallybio Corporation - Common Stock was at 02/23/26 04:00 PM ET
    What is the market capitalization of Rallybio Corporation - Common Stock?
    The market capitalization of Rallybio Corporation - Common Stock is 207.61M
    How many shares of Rallybio Corporation - Common Stock are outstanding?
    Rallybio Corporation - Common Stock has 208M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.